Extrahepatic organs in the development of non-alcoholic fatty liver disease in liver transplant patients.

Abstract

Background and Objective:

Non-alcoholic fatty liver disease (NAFLD) is highly prevalent in patients who undergo liver transplantation (LT). Whereas there is huge data on NAFLD, little is known about NAFLD in LT. In this review, we aim to explore extrahepatic organs and their potential mechanisms in the development of NAFLD in LT patients and discuss current limitations in preclinical and clinical scenarios with suggestions for future study.

Methods:

The following keywords, such as NAFLD, NASH, liver transplant, therapy, pathogenesis and biomarkers, were set for literature retrieval. The articles which were published articles in English till 25th June 2020 in PubMed database were included, and there is no limit for the study design type.

Key Content and Findings:

Following LT, there are significant shifts in the microbiota and farnesoid X receptor may be a potential therapeutic target for NAFLD in LT settings. The roles of probiotics and diet on NALFD remain inconclusive in LT background. Nevertheless, the adipokines and cytokines disorder and local insulin resistance of adipose tissue may contribute to NAFLD process. Bariatric surgeries are promising in controlling de novo and recurrent NAFLD with significant reduction in abdominal adipose tissue, despite the optimal timing is inconclusive in LT cases. Furthermore, circumstantial evidence indicates that miRNA-33a may function as a mediator bridging sarcopenia and NAFLD of post-LT. β-Hydroxy-β-Methyl-Butyrate treatment could improve muscle status in graft recipients and shows protective potential for NAFLD in LT settings.

Conclusions:

Gut, adipose tissue and muscle are intricately intertwined in promoting NAFLD in LT cases. Further animal studies are needed to deepen our understanding of mechanisms in multi-organ crosstalk. High quality clinical trials are warrant for making guidelines and developing management strategies on NAFLD after LT.

• Authors: Renyi Su, Xuyong Wei, Qiang Wei, Di Lu, Zuyuan Lin, Shuo Wang, Chuxiao Shao, Xiao Xu
• Journal: Hepatobiliary surgery and nutrition (Hepatobiliary Surg Nutr) Vol. 11 Issue 3 Pg. 400-411 (Jun 2022) ISSN: 2304-3881 [Print] China (Republic : 1949- )
• PMID: 35693397 (Publication Type: Journal Article, Review)
• Copyright: 2022 Hepatobiliary Surgery and Nutrition. All rights reserved.